Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:29 pm Purchase |
2022-12-31 | 13G | Zymeworks Inc. ZYME |
Redmile Group LLC | 6,175,918 9.800% |
100,000 (+1.65%) |
Filing History |
| 2023-02-14 4:29 pm Sale |
2022-12-31 | 13G | Repare Therapeutics Inc. RPTX |
Redmile Group LLC | 2,684,396 6.400% |
-105,100 (-3.77%) |
Filing History |
| 2023-02-14 4:28 pm Purchase |
2022-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
Redmile Group LLC | 3,878,599 8.000% |
795,098 (+25.79%) |
Filing History |
| 2023-02-14 4:27 pm Purchase |
2022-12-31 | 13G | Kymera Therapeutics, Inc. KYMR |
Redmile Group LLC | 2,673,837 4.900% |
86,107 (+3.33%) |
Filing History |
| 2023-02-14 4:27 pm Purchase |
2022-12-31 | 13G | Krystal Biotech, Inc. KRYS |
Redmile Group LLC | 1,896,645 7.400% |
75,747 (+4.16%) |
Filing History |
| 2023-02-14 4:25 pm Sale |
2022-12-31 | 13G | Entrada Therapeutics, Inc. TRDA |
Redmile Group LLC | 1,854,108 5.900% |
-100,312 (-5.13%) |
Filing History |
| 2023-02-14 4:23 pm Purchase |
2022-12-31 | 13G | Akero Therapeutics, Inc. AKRO |
Redmile Group LLC | 2,632,912 5.600% |
1,030,627 (+64.32%) |
Filing History |
| 2023-02-14 4:22 pm Purchase |
2022-12-31 | 13G | Replimune Group, Inc. REPL |
Redmile Group LLC | 5,740,099 9.900% |
574,968 (+11.13%) |
Filing History |
| 2023-02-14 4:21 pm Purchase |
2022-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
Redmile Group LLC | 3,679,838 9.900% |
480,475 (+15.02%) |
Filing History |
| 2023-02-14 4:21 pm Purchase |
2022-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Redmile Group LLC | 4,899,772 9.900% |
1,941,488 (+65.63%) |
Filing History |
| 2023-02-14 4:21 pm Sale |
2022-12-31 | 13G | Neoleukin Therapeutics, Inc. NLTX |
Redmile Group LLC | 151,528 6.900% |
-64,550 (-29.87%) |
Filing History |
| 2023-02-14 4:20 pm Purchase |
2022-12-31 | 13G | ImmunoGen, Inc. IMGN |
Redmile Group LLC | 19,896,453 8.600% |
274,472 (+1.40%) |
Filing History |
| 2023-02-14 4:20 pm Purchase |
2022-12-31 | 13G | GRITSTONE BIO INC GRTSQ |
Redmile Group LLC | 8,483,322 9.900% |
1,217,808 (+16.76%) |
Filing History |
| 2023-02-14 4:19 pm Purchase |
2022-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
Redmile Group LLC | 7,108,097 9.900% |
1,427,180 (+25.12%) |
Filing History |
| 2023-02-14 4:18 pm Purchase |
2022-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA |
Redmile Group LLC | 393,500 9.900% |
29,551 (+8.12%) |
Filing History |
| 2023-02-14 4:18 pm Purchase |
2022-12-31 | 13G | Annexon, Inc. ANNX |
Redmile Group LLC | 4,897,575 9.900% |
5,882 (+0.12%) |
Filing History |
| 2023-02-14 4:16 pm Purchase |
2022-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
Redmile Group LLC | 28,599,494 9.900% |
194,452 (+0.68%) |
Filing History |
| 2023-02-10 5:18 pm Purchase |
2022-12-31 | 13G | ADC Therapeutics SA ADCT |
Redmile Group LLC | 13,565,249 16.800% |
6,114,220 (+82.06%) |
Filing History |
| 2023-02-08 5:18 pm Purchase |
2023-01-19 | 13G | Advaxis, Inc. ADXS |
Redmile Group LLC | 332,353 6.800% |
332,353 (New Position) |
Filing History |
| 2023-02-08 5:16 pm Sale |
2022-12-31 | 13G | Ayala Pharmaceuticals, Inc. AYLA |
Redmile Group LLC | 0 0.000% |
-1,472,522 (Position Closed) |
Filing History |